Axogen, Inc. Increase (Decrease) in Other Operating Liabilities
Axogen, Inc. (AXGN) reported Increase (Decrease) in Other Operating Liabilities of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-07-29
- Axogen, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was $1.00K.
- Axogen, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was -$1.00K, a 101.59% decline year-over-year.
- Axogen, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $158.00K.
- Axogen, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$34.00K, a 109.66% decline year-over-year.
- Axogen, Inc. increase (decrease) in other operating liabilities for fiscal 2025 was $47.00K, a 88.92% decline from fiscal 2024.
- Axogen, Inc. increase (decrease) in other operating liabilities for fiscal 2024 was $424.00K.
- Axogen, Inc. increase (decrease) in other operating liabilities for fiscal 2023 was -$14.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $0.00 10-Q · filed 2026-07-29 | $158.00K derived: sum of 3 quarters · filed 2026-07-29 | $124.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$1.00K 10-Q · filed 2026-04-28 | $157.00K derived: sum of 2 quarters · filed 2026-04-28 | $123.00K derived: sum of 3 quarters · filed 2026-04-28 | -$17.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $124.00K derived: sum of 2 quarters · filed 2026-02-24 | -$16.00K derived: sum of 3 quarters · filed 2026-07-29 | $47.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | -$34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$174.00K derived: sum of 2 quarters · filed 2026-07-29 | -$111.00K 10-Q · filed 2025-10-29 | -$182.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$77.00K 10-Q · filed 2026-07-29 | -$148.00K derived: sum of 3 quarters · filed 2026-07-29 | $204.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $63.00K 10-Q · filed 2026-04-28 | -$8.00K derived: sum of 2 quarters · filed 2026-04-28 | $344.00K derived: sum of 3 quarters · filed 2026-04-28 | $487.00K derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $281.00K derived: sum of 2 quarters · filed 2026-02-24 | $424.00K derived: sum of 3 quarters · filed 2026-02-24 | $424.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $352.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $495.00K derived: sum of 2 quarters · filed 2025-10-29 | $495.00K 10-Q · filed 2025-10-29 | $495.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $143.00K 10-Q · filed 2025-08-05 | $143.00K derived: sum of 3 quarters · filed 2026-02-24 | $129.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | -$14.00K derived: sum of 3 quarters · filed 2026-02-24 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$14.00K derived: sum of 2 quarters · filed 2026-02-24 | -$14.00K 10-K · filed 2026-02-24 | |
| 2023-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$14.00K 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |